A low-cost, fast, and efficient water treatment technology that uses titanium dioxide and graphene nanocomposite photocatalysis under UV illumination to remove chloramine. Designed for scalable deployment on flexible substrates, with applications in residential water purification and home dialysis systems.
This technology addresses the challenge of chloramine removal in water treatment through a nanocomposite photocatalysis approach. Chloramine, a common disinfectant used in municipal water, must be removed before water can be used in sensitive applications such as home dialysis. The proposed solution combines titanium dioxide and graphene under UV illumination to achieve rapid, efficient chloramine degradation at a low cost. The technology is designed to be scalable through roll-to-roll film manufacturing, making it suitable for mass production and widespread deployment in residential water filtration systems.
How it works:
Key features:
This technology is currently at an early-to-mid stage of development. The research team has outlined a clear validation pathway: initial laboratory validation of the combined photocatalysis degradation rate compared to UV-only treatment, followed by substrate deposition and photoelectrocatalysis optimization, and culminating in the design and fabrication of a small-size chloramine filter for home dialysis applications. The technology has not yet been validated in a real-world or commercial setting, but the proposed development plan provides a structured path toward a functional prototype suitable for residential water treatment.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.